Literature DB >> 18304554

The apolipoprotein(a) gene: linkage disequilibria at three loci differs in African Americans and Caucasians.

Jill Rubin1, Han Jo Kim, Thomas A Pearson, Steve Holleran, Lars Berglund, Rajasekhar Ramakrishnan.   

Abstract

Lipoprotein(a) (Lp(a)) is an independent, genetically regulated cardiovascular risk factor. Lp(a) plasma levels are largely determined by the apolipoprotein(a) (apo(a)) component, and differ across ethnicity. Although a number of polymorphisms in the apo(a) gene have been identified, apo(a) genetic regulation is not fully understood. To study the relation between apo(a) gene variants, we constructed haplotypes and assessed linkage equilibrium in African Americans and Caucasians for three widely studied apo(a) gene polymorphisms (apo(a) size, +93 C/T and pentanucleotide repeat region (PNR)). Apo(a) size allele frequency distributions were different across ethnicity (p<0.01). For African Americans, PNR frequencies were similar across apo(a) sizes, suggesting linkage equilibrium. For Caucasians, the PNR and the PNR-C/T haplotype frequencies differed for large and small apo(a), with the T and PNR 9 alleles associated with large apo(a) size (p<0.0002); also, the PNR 9 allele was more common on a T allele, while PNR 8 was more common on a C allele. On a C allele background, small PNR alleles were more common and the PNR 10 allele less common among African Americans than Caucasians (p<0.001). The ethnic difference in apo(a) size distribution remained controlling for C/T and PNR alleles (p=0.023). In conclusion, allele and haplotype frequencies and the nature of the linkage disequilibrium differed between African Americans and Caucasians at three apo(a) gene polymorphisms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18304554      PMCID: PMC2784197          DOI: 10.1016/j.atherosclerosis.2008.01.002

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  42 in total

1.  Apolipoprotein [a] genotype influences isoform dominance pattern differently in African Americans and Caucasians.

Authors:  Jill Rubin; Furcy Paultre; Catherine H Tuck; Steve Holleran; Roberta G Reed; Thomas A Pearson; Christopher M Thomas; Rajasekhar Ramakrishnan; Lars Berglund
Journal:  J Lipid Res       Date:  2002-02       Impact factor: 5.922

2.  Statistical estimation and pedigree analysis of CCR2-CCR5 haplotypes.

Authors:  V J Clark; N Metheny; M Dean; R J Peterson
Journal:  Hum Genet       Date:  2001-06       Impact factor: 4.132

3.  The association of serum lipoprotein(a) levels, apolipoprotein(a) size and (TTTTA)(n) polymorphism with coronary heart disease.

Authors:  A Császár; G Füst; B Nagy; C Szalai; I Karádi; J Duba; Z Prohászka; L Horváth; H Dieplinger
Journal:  Clin Chim Acta       Date:  2001-07-05       Impact factor: 3.786

4.  Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies.

Authors:  J Danesh; R Collins; R Peto
Journal:  Circulation       Date:  2000-09-05       Impact factor: 29.690

5.  Fluorescence-based, nonradioactive method for efficient detection of the pentanucleotide repeat (TTTTA)(n) polymorphism in the apolipoprotein(a) gene.

Authors:  J Rubin; T A Pearson; R G Reed; L Berglund
Journal:  Clin Chem       Date:  2001-10       Impact factor: 8.327

6.  Plasma sphingomyelin level as a risk factor for coronary artery disease.

Authors:  X C Jiang; F Paultre; T A Pearson; R G Reed; C K Francis; M Lin; L Berglund; A R Tall
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-12       Impact factor: 8.311

7.  High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men.

Authors:  F Paultre; T A Pearson; H F Weil; C H Tuck; M Myerson; J Rubin; C K Francis; H F Marx; E F Philbin; R G Reed; L Berglund
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-12       Impact factor: 8.311

8.  Small apolipoprotein(a) size predicts mortality in end-stage renal disease: The CHOICE study.

Authors:  J Craig Longenecker; Michael J Klag; Santica M Marcovina; Neil R Powe; Nancy E Fink; Federico Giaculli; Josef Coresh
Journal:  Circulation       Date:  2002-11-26       Impact factor: 29.690

9.  Apo[a] size and PNR explain African American-Caucasian differences in allele-specific apo[a] levels for small but not large apo[a].

Authors:  Jill Rubin; Han Jo Kim; Thomas A Pearson; Steve Holleran; Rajasekhar Ramakrishnan; Lars Berglund
Journal:  J Lipid Res       Date:  2006-02-22       Impact factor: 5.922

10.  Does apolipoprotein E polymorphism influence susceptibility to malaria?

Authors:  M A Wozniak; E B Faragher; J A Todd; K A Koram; E M Riley; R F Itzhaki
Journal:  J Med Genet       Date:  2003-05       Impact factor: 6.318

View more
  7 in total

Review 1.  Lipoprotein(a): genotype-phenotype relationship and impact on atherogenic risk.

Authors:  Byambaa Enkhmaa; Erdembileg Anuurad; Wei Zhang; Tina Tran; Lars Berglund
Journal:  Metab Syndr Relat Disord       Date:  2011-07-12       Impact factor: 1.894

Review 2.  Lipoprotein(a) metabolism: potential sites for therapeutic targets.

Authors:  Jane Hoover-Plow; Menggui Huang
Journal:  Metabolism       Date:  2012-10-04       Impact factor: 8.694

Review 3.  [Impact of lipid metabolism parameters on the development and progression of coronary artery disease : An update].

Authors:  D Sinning; D M Leistner; U Landmesser
Journal:  Herz       Date:  2016-06       Impact factor: 1.443

4.  Lipoprotein(a) hyperlipidemia as cardiovascular risk factor: pathophysiological aspects.

Authors:  Gerd Schmitz; Evelyn Orsó
Journal:  Clin Res Cardiol Suppl       Date:  2015-04

5.  Lipoprotein(a) and its role in inflammation, atherosclerosis and malignancies.

Authors:  Evelyn Orsó; Gerd Schmitz
Journal:  Clin Res Cardiol Suppl       Date:  2017-03

Review 6.  Lipoprotein(a): a promising marker for residual cardiovascular risk assessment.

Authors:  Anping Cai; Liwen Li; Ying Zhang; Yujin Mo; Weiyi Mai; Yingling Zhou
Journal:  Dis Markers       Date:  2013-10-22       Impact factor: 3.434

7.  Investigation of a nonsense mutation located in the complex KIV-2 copy number variation region of apolipoprotein(a) in 10,910 individuals.

Authors:  Silvia Di Maio; Rebecca Grüneis; Gertraud Streiter; Claudia Lamina; Manuel Maglione; Sebastian Schoenherr; Dietmar Öfner; Barbara Thorand; Annette Peters; Kai-Uwe Eckardt; Anna Köttgen; Florian Kronenberg; Stefan Coassin
Journal:  Genome Med       Date:  2020-08-21       Impact factor: 15.266

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.